Abstract
Psychiatric manifestations are not uncommon presentation of thyroid dysfunction. Although, depression and anxiety are likely to occur in both hypo and hyperthyroidism, there are much more mental symptoms which may take place within a course of thyroid dysfunction. Those symptoms may present as a mood, psychotic, cognitive and anxiety in character. The mechanism of such mental symptoms in relation to thyroid abnormalities is still unclear. Proper management is expected to bring about good outcome.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Esposito S, Prange Jr AJ, Golden RN. The thyroid axis and mood disorders: overview and future prospects. Psychopharmacol Bull. 1997;33(2):205–17.
Pearce JMS. Myxoedema and Sir William Withey Gull (1816–1890). J Neurol Neurosurg Psychiatry. 2006;77(5):639.
Harrison NA, Michael D, Kopelman MD. Endocrine diseases and metabolic disorders. In: LISHMAN’S organic psychiatry: a textbook of neuropsychiatry. 4th ed. Wiley-Blackwell p. 628–35.
Jackson IMD, Asamoah EO. Thyroid function in clinical depression: insights and uncertainties. Thyroid Today. 1999;22(2):1–11.
Thomas DG Jr. Identifying hypothyroidism’s psychiatric presentations. Curr Psychiatry. 2006;5:98–117.
Stern RA, Robinson B, Thorner AR, et al. A survey study of neuropsychiatric complaints in patients with Graves’ disease. J Neuropsychiatry Clin Neurosci. 1996;8:181–5.
Kraemer HC. Evaluating medical tests: objective and quantitative guidelines. Newbury Park: SAGE Publications; 1992. p. 151–8.
Maser JD, Akiskal HS. “Spectrum concepts in major mental disorders”. Psychiatr Clin North Am. 2002;25:xi–xiii.
Angst J, Merikangas K. “The depressive spectrum: diagnostic classification and course”. J Affect Disord. 1997;45:31–9; 39–40.
Wayne C, Joseph L, Maura L. Implications for neurocircuitry models of depression. Brain Struct Funct. 2008;213:93–118.
Kandel ER. Disorders of mood: depression, mania and anxiety disorders. J Prin Neural Sci. 2000;1209–26 chapter 61.
Etkin A, Katherine E, Alan F, et al. Disrupted amygdalar subregion functional connectivity and evidence of a compensatory network in generalized anxiety disorder. Arch Gen Psychiatry. 2009;66:1361–72.
Green MF. Schizophrenia revealed: from neurons to social interactions. New York: W.W Norton; 2001. p. 207.
Fumi K, Xue-Lian Q, Travis M, et al. Differences in intrinsic functional organization between dorsolateral prefrontal and posterior parietal cortex. Cereb Cortex. 2014;24:2334–49.
Kennedy SH. Core symptoms of major depressive disorder: relevance for diagnosis and treatment. Dialogues Clin Neurosci. 2008;10:271–7.
Whybrow P, Prange TR. Mental changes accompanying thyroid gland dysfunction. Arch Gen Psychiatry. 1969;20:48–63.
Braverman LE, Utiger RD. Werner and Ingbar’s the thyroid: a fundamental and clinical text. 8th ed. Philadelphia: Lippincott Williams & Wilkins; 2000. p. 837–42.
Haggerty JJ, Stern RA, Mason GA, et al. Subclinical hypothyroidism: a modifiable risk factor for depression? Am J Psyciatry. 1993;150:508–10.
Haggerty JJ, Prange AJ. Borderline hypothyroidism and depression. Ann Rev Med. 1995;46:37–46.
Howland RH. Thyroid dysfunction in refractory depression: implications for pathophysiology and treatment. J Clin Psychiatry. 1993;54:47–54.
Vonk R, van der Schot AC, Kahn RS, Nolen WA, Drexhage HA. Is autoimmune thyroiditis part of the genetic vulnerability (or an endophenotype) for bipolar disorder. Biol Psychiatry. 2007;62:135–40.
Kupka RW, Nolen WA, Post RM, et al. High rate of autoimmune thyroiditis in bipolar disorder: lack of association with lithium exposure. Biol Psychiatry. 2002;51:305–11.
Chang KD, Keck PE, Stanton SP, McElroy SL, Strakowski SM, Geracioti TD. Differences in thyroid function between bipolar manic and mixed states. Biol Psychiatry. 1998;43:730–3.
Bauer MS, Whybrow PC. Rapid cycling bipolar affective disorder. Treatment of refractory rapid cycling with high-dose levothyroxine: a preliminary study. Arch Gen Psychiatry. 1990;47:435–40.
Moret C. Combination/augmentation strategies for improving the treatment of depression. Neuropsych Dis Treat. 2005;1:301–9.
Kelly T, Lieberman DZ. The use of triiodothyronine as an augmentation agent in treatment-resistant bipolar II and bipolar disorder NOS. J Affect Disord. 2009;116:222–6.
Tor PC, Lee HY, Fones CL. Late-onset mania with psychosis associated with hypothyroidism in an elderly Chinese lady. Singapore Med J. 2007;48:354–7.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th ed, text revision. Washington, DC: American Psychiatric Association; 2000.
Engum A, Bjøro T, Mykletun A, Dahl AA. Thyroid autoimmunity, depression and anxiety; are there any connections? An epidemiological study of a large population. J Psychosom Res. 2005;59:263–8.
Hennessey JV, Jackson IM. The interface between thyroid hormones and psychiatry. Endocrinologist. 1996;6:214–23.
Engum A, Bjøro T, Mykletun A, Dahl AA. An association between depression, anxiety and thyroid function: a clinical fact or an artefact? Acta Psychiatr Scand. 2002;106:27–34.
Kolakowsk T, Swigar ME. Thyroid function in depression and alcohol abuse: a retrospective study. Arch Gen Psychiatry. 1977;34:984–8.
Bocchetta A, Loviselli A. Lithium treatment and thyroid abnormalities. Clin Pract Epidemiol Ment Healt. 2006;2:23.
Gau CS, Chang CJ, Tsai FJ, Chao PF, Gau SS. Association between mood stabilizers and hypothyroidism in patients with bipolar disorders: a nested, matched case-control study. Bipolar Disord. 2010;12:253–63.
Gelder MG, Mayou R, Geddes J. Psychiatry. New York: Oxford University Press; 2005. p. 12.
Josephson AM, Mackenzie TB. Thyroid-induced mania in hypothyroid patients. Br J Psychiatr. 1980;137:222–8.
Benjamin JS, Harold IK, Virginia AS. Kaplan & Sadock’s synopsis of psychiatry: behavioral sciences/clinical psychiatry. 10th ed. Philadelphia: Lippincott Williams & Wilkin; 2007.
Brownlie BEW, Rae AM, Walshe JWB, et al. Psychoses associated with thyrotoxicosis: ‘thyrotoxic psychosis’. A report of 18 cases, with statistical analysis of incidence. Eur Endocrinol. 2000;142:438–44.
Martin FI, Deam DR. Hyperthyroidism in elderly hospitalised patients. Clinical features and treatment outcomes. Med J Aust. 1996;164:200–3.
Wu T, Flowers JW, Tudiver F, et al. Subclinical thyroid disorders and cognitive performance among adolescents in the United States. BMC Pediatr. 2006;6:12.
Schlote B, Schaaf L, Schmidt R, et al. Mental and physical state in subclinical hyperthyroidism: investigations in a normal working population. Biol Psychiatry. 1992;32:48–56.
Román GC, Ghassabian A, Bongers-Schokking JJ, et al. Association of gestational maternal hypothyroxinemia and increased autism risk. Ann Neurol. 2013;74:733–42.
Patel G, Fancher TL. Generalized anxiety disorder. Ann Intern Med. 2013;159:ITC6–1.
Fava GA, Porcelli P, Rafanelli C, et al. The spectrum of anxiety disorders in the medically ill. J Clin Psychiatry. 2010;71:910–4.
Kathol RG, Turner R, Delahunt J. Depression and anxiety associated with hyperthyroidism: response to antithyroid therapy. Psychosomatics. 1986;27:501–5.
Jadresic DP. Psychiatric aspects of hyperthyroidism. J Psychosom Res. 1990;34:603–15.
Bauer M, Hellweg R, Graf KJ, et al. Treatment of refractory depression with high dose thyroxine. Neuropsychopharmacology. 1998;18:444–55.
American Psychiatric Association. Practice guideline for the treatment of patients with bipolar disorder (revision). Am J Psychiatry. 2002;159:1–50.
Mitchell L. Evaluation of the association between St. John’s wort and elevated thyroid-stimulating hormone. Pharmacotherapy. 2001;21:1574–8.
Kibirige D, Luzinda K, Ssekitoleko R. Spectrum of lithium induced thyroid abnormalities: a current perspective. Thyroid Res. 2013;6(1):3.
Barbesino G. Drugs affecting thyroid function. Thyroid. 2010;20:763–70.
Bunevicius R, Kazanavicius G, Zalinkevicius R, et al. Effects of thyroxine as compared with thyroxine plus triiodothyronine in patients with hypothyroidism. N Engl J Med. 1999;340:424–9.
Clyde PW, Harari AE, Getta EJ, et al. Combined levothyroxine plus liothyronine compared with levothyroxine alone in primary hypothyroidism. A randomized controlled trial. JAMA. 2003;290:2952–8.
Cooper DS. Combined T4 and T3 therapy: back to the drawing board. JAMA. 2003;290:3002–4.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Elmaghraby, E. (2016). Thyroid Dysfunction and Mental Disorders. In: Imam, S., Ahmad, S. (eds) Thyroid Disorders. Springer, Cham. https://doi.org/10.1007/978-3-319-25871-3_15
Download citation
DOI: https://doi.org/10.1007/978-3-319-25871-3_15
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-25869-0
Online ISBN: 978-3-319-25871-3
eBook Packages: MedicineMedicine (R0)